Summary by: Mervyn Singer
Multiple biomarkers – physiological, biochemical, biological – can prognosticate early in critical illness, even in the ED. This implies the die is already cast (literally as well as figuratively) so we are simply prolonging death is those predetermined to die. We thus need to adopt a completely different strategy for such patients. This also applies to trial design, especially where survival is the endpoint.
In providing critical care we sometimes need to make immediate decisions on who’s dead and who’s not. How are...
What can hospital specialties learn from teaching and training in prehospital and retrieval medicine? A medical education enthusiast’s thoughts...
As more people survive episodes of severe sepsis the serious long term adverse effects on health and quality of...
This talk uses a case study approach to discuss the need for technical accuracy in resuscitation practice.
What happens in a mass casualty disaster when you run out of beds? Out of ventilators? Out of blood?...
Will we ever work out which patients benefit from a decompressive crainectomy?
Peer review is central to science, but ironically is faith rather than evidence based in that it lacks evidence...
